Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH2 | P25021 | 1/20 | 0.53 |
| ▸ | HTR5A | P47898 | 1/20 | 0.53 |
| ▸ | ADORA3 | P0DMS8 | 12/20 | 0.45 |
| ▸ | ADORA1 | P30542 | 12/20 | 0.45 |
| ▸ | ADORA2A | P29274 | 4/20 | 0.45 |
| ▸ | HSP90B1 | P14625 | 1/20 | 0.44 |
| ▸ | HTR2B | P41595 | 9/20 | 0.43 |
| ▸ | HTR2C | P28335 | 6/20 | 0.43 |
| ▸ | TMIGD3 | P0DMS9 | 3/20 | 0.42 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29574073 | 0.90 | HTR2B (0.51) | HRH2HTR5AADORA3ADORA1ADORA2A | |
| SCHEMBL29574436 | 0.84 | ADORA1 (0.57) | ADORA3ADORA1ADORA2AHSP90B1HTR2B | |
| SCHEMBL29574455 | 0.84 | ADORA3 (0.55) | ADORA3ADORA1ADORA2AHTR2BHTR2C | |
| SCHEMBL29573969 | 0.82 | HRH2 (0.54) | HRH2HTR5AADORA3ADORA1ADORA2A | |
| SCHEMBL22757377 | 0.78 | ADORA3 (0.58) | HRH2HTR5AADORA3ADORA1ADORA2A | |
| SCHEMBL31350147 | 0.75 | HTR2B (0.70) | HRH2HTR5AADORA3ADORA1ADORA2A | |
| SCHEMBL22757352 | 0.75 | ADORA3 (0.54) | HRH2HTR5AADORA3ADORA1ADORA2A | |
| SCHEMBL23201583 | 0.74 | HRH2 (0.70) | HRH2HTR5AADORA3ADORA1ADORA2A | |
| SCHEMBL29573781 | 0.74 | HTR2B (0.73) | HRH2ADORA3ADORA1ADORA2AHTR2B | |
| SCHEMBL29575031 | 0.74 | ADORA3 (0.46) | ADORA3ADORA1ADORA2AHTR2BHTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4196219-A1 | A3 ADENOSINE RECEPTOR AGONISTS FOR USE IN MEDICINE | Biointervene, Inc. (US) | 2023-06-21 | — | — | EP | disclosed |
| WO-2022040241-A1 | A3 ADENOSINE RECEPTOR AGONISTS FOR USE IN MEDICINE | BIOINTERVENE, INC. (US) | 2022-02-24 | — | — | WO | disclosed |